Physician profile
Matthew Howe
NPI 1154462240
$556.55
in general payments reported to CMS, 2019-2025
12 companies · $212 in 2025
The $212 reported for 2025 was more than what 75% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.60 · 2020: $11.50 · 2021: $32.68 · 2022: $56.67 · 2023: $61.14 · 2024: $88.94 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $179 · Food and Beverage: $159 · Long Term Medical Supply Or Device Loan: $24.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $178.80 |
| Food and Beverage | $158.82 |
| Long Term Medical Supply Or Device Loan | $24.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $203.28 | 2024-2025 | Hillrom - Connex Vital Signs Monitor, Hillrom - Spot Vision Screener |
| Merck Sharp & Dohme LLC | $109.74 | 2019-2025 | Gardasil 9, Vaxelis, Proquad |
| Kaleo, INC. | $65.41 | 2019-2024 | Auvi-Q |
| Corium, LLC | $32.91 | 2022-2023 | Azstarys |
| Pfizer INC. | $30.33 | 2019-2024 | |
| Neos Therapeutics, LP | $28.47 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $20.10 | 2021 | |
| Seqirus USA INC | $17.77 | 2025 | Flucelvax |
| Alk-Abello, INC | $16.88 | 2024 | Ragwitek, Odactra, Grastek |
| Phadia US INC. | $16.68 | 2023 | Immunocap |
| Cranial Technologies, INC | $14.98 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Howe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.